Načítá se...
Emerging drugs for preeclampsia – the endothelium as a target
Preeclampsia, the development of new onset hypertension and proteinuria during pregnancy, affects ~ 3 – 8% of all pregnancies and is a leading cause of maternal and perinatal morbidity and mortality. Despite the potentially devastating effects of this disease on the mother and the baby and the recen...
Uloženo v:
| Vydáno v: | Expert Opin Emerg Drugs |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4697827/ https://ncbi.nlm.nih.gov/pubmed/26138471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14728214.2015.1062875 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|